1. Analysis of circulating tumour DNA to identify patients with epidermal growth factor receptor–positive non-small cell lung cancer who might benefit from sequential tyrosine kinase inhibitor treatment. (May 2021) Authors: Provencio, Mariano; Serna-Blasco, Roberto; Franco, Fabio; Calvo, Virgina; Royuela, Ana; Auglytė, Milda; Sánchez-Hernández, Alfredo; de Julián Campayo, María; García-Girón, Carlos; Dómine, Manuel; Blasco, Ana; Sánchez, José M.; Oramas, Juana; Bosch-Barrera, Joaquim; Sala, María Á.; Sereno, María; ... Journal: European journal of cancer Issue: Volume 149(2021) Page Start: 61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Interferon gamma, an important marker of response to immune checkpoint blockade in non-small cell lung cancer and melanoma patients. (13th January 2018) Authors: Karachaliou, Niki; Gonzalez-Cao, Maria; Crespo, Guillermo; Drozdowskyj, Ana; Aldeguer, Erika; Gimenez-Capitan, Ana; Teixido, Cristina; Molina-Vila, Miguel Angel; Viteri, Santiago; De Los Llanos Gil, Maria; Algarra, Salvador Martin; Perez-Ruiz, Elisabeth; Marquez-Rodas, Ivan; Rodriguez-Abreu, Delv... Journal: Therapeutic advances in medical oncology Issue: Volume 10(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗